Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon-associated retinopathy]

H Okuno1, T Hirota, Y Shiozaki

  • 1Third Department of Internal Medicine, Kansai Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 1, 1994
PubMed
Summary

Interferon (IFN) therapy for hepatitis C can cause retinopathy, marked by vision changes and lesions. This condition often improves on its own, allowing continued IFN treatment with careful eye monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Terahertz Electronic and Spin Currents in Wafer-Scale Van der Waals Bi<sub>2</sub>Se<sub>3</sub>/WSe<sub>2</sub> Heterostructures and Polymorphs.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Discharge characteristics of steady-state high-density plasma source based on cascade arc discharge with hollow cathode.

The Review of scientific instruments·2022
Same author

Study of the K_{L}→π^{0}νν[over ¯] Decay at the J-PARC KOTO Experiment.

Physical review letters·2021
Same author

Characteristics of plasma window with various channel diameters for accelerator applications.

The Review of scientific instruments·2020
Same author

Impact of kinetics on the growth of GaN on graphene by plasma-assisted molecular beam epitaxy.

Nanotechnology·2019
Same author

Remote epitaxy using graphene enables growth of stress-free GaN.

Nanotechnology·2019

Area of Science:

  • Ophthalmology
  • Hepatology
  • Pharmacology

Background:

  • Interferon (IFN) therapy is a common treatment for chronic hepatitis C.
  • A significant proportion of patients undergoing IFN treatment develop retinopathy.
  • IFN-associated retinopathy presents with specific ocular findings.

Observation:

  • IFN-associated retinopathy manifests as ischemic lesions (cotton-wool spots) and hemorrhages near the optic disc.
  • Symptoms may include visual acuity impairment or 'flying specks', though many patients remain asymptomatic.
  • Onset typically occurs 1-3 months after initiating IFN therapy.

Findings:

  • IFN-associated retinopathy generally improves spontaneously without specific ophthalmic intervention.
  • Diabetic complications or decreased platelet counts can worsen the retinopathy.

Related Experiment Videos

  • Continued IFN therapy is often feasible with diligent ophthalmologic monitoring.

    • Implications:

    • Routine ophthalmologic follow-up is crucial for all patients receiving IFN therapy.
    • Early detection and monitoring can prevent severe visual impairment.
    • Understanding IFN's ocular side effects aids in managing chronic hepatitis C treatment.